Case Report {#sec1_1}
===========

A 52-year-old Caucasian woman was admitted to our hospital from the nursing home due to refusal of percutaneous endoscopic gastrostomy tube feeding and altered mental status, which was attributed to hypoglycemia and urinary tract infection. Her medical history was significant for long-standing severe anorexia nervosa, depression and recent percutaneous endoscopic gastrostomy tube placement for nutritional support at another hospital. She was allergic to ciprofloxacin and penicillin and her nursing home medications included multivitamin, megestrol, ferrous sulfate, calcium carbonate, ranitidine, thiamine, folic acid, and olanzapine.

Upon admission, her weight was 21 kg and her BMI was 7.9, which amounted to approximately 40%percnt; of her ideal body weight. The vital signs were normal. The patient was bed bound, alert and well oriented. The physical exam revealed dry skin, excoriations all over the body, brittle nails, pallor and profound emaciation with bitemporal wasting. Her abdomen was scaphoid without organomegaly, and she had a percutaneous endoscopic gastrostomy tube with granulation tissue surrounding the stoma. There were no stigmata of chronic liver disease. The remainder of her physical examination was unremarkable.

Laboratory investigations revealed hemoglobin of 8.4 g/dl, white cell count of 3.5 k/μl, platelet count of 230 k/μl, prothrombin time of 12 s and activated partial thromboplastin time of 29 s, normal serum electrolytes except for a blood sugar level of 56. Her liver function tests showed serum alanine aminotransferase of 32 units/l, serum aspartate aminotransferase of 32 units/l and serum total bilirubin of 0.6 mg/dl.

She continued to refuse oral and tube feeding and she had intermittent episodes of hypoglycemia. She was evaluated by psychiatrists and was deemed to lack decisional capacity. It was recommended that percutaneous endoscopic gastrostomy tube feeding be imposed for nutritional support. After consultation with the nutritional team, tube feeding was begun at 400 kcal/day and advanced gradually over the next 5 days to 900 kcal/day.

Five days after the initiation of feeding, she developed tachycardia and lab work revealed electrolyte abnormalities such as hypophosphatemia (phosphorus 0.8 mg/dl) and hypokalemia (potassium 2.9 mEq/l) (fig. [1](#F1){ref-type="fig"}). An electrocardiogram was done, which showed sinus tachycardia with some premature ventricular complexes and prolonged QT interval (QTc 472). She was then evaluated by cardiologists and nutritional teams. A diagnosis of refeeding syndrome was made, and the patient was transferred to the telemetry unit for further management. Further laboratory tests revealed elevated transaminases (alanine aminotransferase 193 units/l, aspartate aminotransferase 173 units/l), alkaline phosphatase (392 IU/l) and bilirubin (1.4 mg/dl), which were normal upon admission (fig. [2](#F2){ref-type="fig"}). A consultation with a gastroenterologist was called. Viral hepatitis was excluded by serological tests and autoimmune workup, including anti-smooth muscle antibody, anti-liver/kidney microsomal antibody, antinuclear antibody and antimitochondrial antibody, was negative. Serum ceruloplasmin level was normal. Other causes of hepatitis such as hepatotoxic drugs were excluded. The liver and pancreas appeared normal on a computed tomogram. An abdominal ultrasound revealed normal echotexture of the liver without intra- or extrahepatic biliary dilatation and normal Doppler evaluation of the hepatic and portal vein blood flow.

Infusions of potassium phosphate and magnesium sulfate were administered in addition to oral potassium phosphate supplements. Intravenous thiamine was given. Her enteral intake was reduced and daily electrolyte levels were obtained along with regular monitoring of the liver function tests. The liver enzymes started improving after reduction of the tube feeding rate. Electrolytes also normalized over the next few days and the patient was eventually discharged.

Discussion {#sec1_2}
==========

Anorexia nervosa is characterized by severe protein energy malnutrition, abnormally low body weight and is often accompanied by additional psychopathological disorders \[[@B1]\]. Several studies and case reports have highlighted increases in serum liver enzymes in patients with anorexia nervosa or extreme malnutrition \[[@B2]\]. The majority of them have reported abnormal liver function test results occurring prior to the initiation of any nutritional supplementation and improvement of enzymes upon feeding. Hepatocellular injury in such patients has sometimes been called starvation hepatitis and is attributed to several mechanisms triggered by malnutrition including apoptosis/autophagy, hypoperfusion of the liver, hypoxia, oxidative stress, and iron deposition \[[@B3], [@B4]\].

Rarely, there have been reports of anorexic patients with rapid and profound elevations in liver enzymes, specifically transaminases upon initial refeeding associated with refeeding syndrome \[[@B5], [@B6]\]. A Medline search using the key words 'anorexia nervosa', 'refeeding syndrome' and 'abnormal liver function tests' revealed two case reports from 2000 to 2014 \[[@B7], [@B8]\].

Refeeding syndrome is a potentially lethal condition, which is broadly defined as severe electrolyte and fluid shifts associated with metabolic abnormalities in malnourished patients undergoing refeeding either orally, enterally, or parenterally. Rarely, asymptomatic mild elevations of liver enzymes may be seen during refeeding. A hepatic manifestation as part of metabolic abnormalities can occur during the initial few weeks of refeeding. They are more common in those patients being refed enterally or with total parenteral nutrition. Usually, elevations in aspartate aminotransferase and alanine aminotransferase are noted and may sometimes be followed by a rise in alkaline phosphatase and bilirubin. Usually, these abnormalities revert to normal levels upon reduction of the rate of feeding.

The pathophysiology of this has not been clarified, but a few hypotheses have been postulated \[[@B9]\] and out of them refeeding steatosis/steatohepatitis has gained the most attention. It is attributed to fat accumulation in the hepatocytes secondary to excessive dextrose and carbohydrate supplementation in a severely malnourished patient during the refeeding phase \[[@B10], [@B11], [@B12]\].

We conclude that the development of refeeding syndrome may manifest as abnormal liver function along with electrolyte abnormalities. We recommend close monitoring of liver function tests in patients who are being refed after a long period of starvation as abnormal liver chemistry values may be a harbinger of the refeeding syndrome. We also emphasize the fact that one should 'start low and go slow' in the management of refeeding in anorexia nervosa patients.
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